Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2019

01-10-2019 | Breast Cancer | Breast Oncology

Breastfeeding and Breast Cancer: Managing Lactation in Survivors and Women with a New Diagnosis

Authors: Helen M. Johnson, MD, Katrina B. Mitchell, MD

Published in: Annals of Surgical Oncology | Issue 10/2019

Login to get access

Abstract

Background

Supporting breastfeeding is a global health priority, yet few clinical guidelines exist to guide surgical oncologists in managing lactation during or after breast cancer treatment.

Methods

The literature was reviewed to identify evidence-based strategies for managing lactation during multidisciplinary breast cancer treatment or among breast cancer survivors.

Results

The majority of the evidence is from observational studies, with some higher levels of evidence, including systematic reviews and meta-analyses. Several significant gaps in knowledge remain.

Conclusions

This review serves as a comprehensive resource of evidence-based recommendations for managing lactation in breast cancer survivors and breastfeeding women with a new breast cancer diagnosis.
Literature
1.
2.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRef
3.
Callihan EB, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat. 2013;138(2):549–59.CrossRefPubMedPubMedCentral
4.
Faupel-Badger JM, Arcaro KF, Balkam JJ, et al. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst. 2013;105(3):166–74.CrossRefPubMed
5.
Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s Call to Action to Support Breastfeeding. Rockville (MD): Office of the Surgeon General (US); 2011. Rates of Breastfeeding. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK52681/​. Accessed 4 Jan 2019.
6.
The Lancet. Breastfeeding: a missed opportunity for global health. Lancet. 2017;390(10094):532.
7.
Henry M, Huang LN, Sproule BJ, Cardonick EH. The psychological impact of a cancer diagnosed during pregnancy: determinants of long-term distress. Psychooncology. 2012;21(4):444–50.CrossRefPubMed
8.
9.
10.
11.
Gorman JR, Usita PM, Madlensky L, Pierce JP. A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J Cancer Surviv. 2009;3(3):181–91.CrossRefPubMedPubMedCentral
12.
Azim HA, Bellettini G, Gelber S, Peccatori FA. Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res Treat. 2009;114(1):7–12.CrossRefPubMed
13.
Connell S, Patterson C, Newman B. A qualitative analysis of reproductive issues raised by young Australian women with breast cancer. Health Care Women Int. 2006;27(1):94–110.CrossRefPubMed
14.
Helewa M, Lévesque P, Provencher D, et al. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can. 2002;24(2):164–80; quiz 181-4.CrossRefPubMed
15.
16.
Chapman T, Pincombe J, Harris M. Antenatal breast expression: a critical review of the literature. Midwifery. 2013;29(3):203–10.CrossRefPubMed
17.
Leal SC, Stuart SR, Carvalho HA. Breast irradiation and lactation: a review. Expert Rev Anticancer Ther. 2013;13(2):159–64.CrossRefPubMed
18.
Schlenz I, Kuzbari R, Gruber H, Holle J. The sensitivity of the nipple-areola complex: an anatomic study. Plast Reconstr Surg. 2000;105(3):905–9.CrossRefPubMed
19.
Karacalar A, Orak I, Aydýn O, Yaln T. Spontaneous recanalization of the divided lactiferous duct in the rat. Ann Plast Surg. 2005;54(2):196–200.CrossRefPubMed
20.
Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiation-induced changes in the breast. Hum Pathol. 1984;15(6):545–50.CrossRefPubMed
21.
Moore GH, Schiller JE, Moore GK. Radiation-induced histopathologic changes of the breast: the effects of time. Am J Surg Pathol. 2004;28(1):47–53.CrossRefPubMed
22.
23.
Guix B, Tello JI, Finestres F, Palma C, Martínez A. Lactation after conservative treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2000;46(2):515–6.CrossRefPubMed
24.
Stopenski S, Aslam A, Zhang X, Cardonick E. After chemotherapy treatment for maternal cancer during pregnancy: is breastfeeding possible? Breastfeed Med. 2017;12:91–7.CrossRefPubMed
25.
26.
Shaaban MM. Suppression of lactation by an antiestrogen, tamoxifen. Eur J Obstet Gynecol Reprod Biol. 1975;4(5):167–9.CrossRefPubMed
27.
Masala A, Delitala G, Lo Dico G, Stoppelli I, Alagna S, Devilla L. Inhibition of lactation and inhibition of prolactin release after mechanical breast stimulation in puerperal women given tamoxifen or placebo. Br J Obstet Gynaecol. 1978;85(2):134–7.CrossRefPubMed
28.
Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355–77.CrossRefPubMed
29.
Pagani O, Ruggeri M, Manunta S, et al. Pregnancy after breast cancer: are young patients willing to participate in clinical studies? Breast. 2015;24(3):201–7.CrossRefPubMed
30.
Stuebe AM, Horton BJ, Chetwynd E, Watkins S, Grewen K, Meltzer-Brody S. Prevalence and risk factors for early, undesired weaning attributed to lactation dysfunction. J Womens Health (Larchmt). 2014;23(5):404–12.CrossRef
31.
32.
Schackmuth EM, Harlow CL, Norton LW. Milk fistula: a complication after core breast biopsy. AJR Am J Roentgenol. 1993;161(5):961–2.CrossRefPubMed
33.
Barker P. Milk fistula: an unusual complication of breast biopsy. J R Coll Surg Edinb. 1988;33(2):106.PubMed
34.
diFlorio-Alexander RM, Slanetz PJ, Moy L, et al. ACR appropriateness criteria. J Am Coll Radiol. 2018;15(11S):S263–75.CrossRefPubMed
35.
Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 2010;257(1):246–53.CrossRefPubMed
36.
Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol. 2013;200(2):321–8.CrossRefPubMed
37.
Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics. 2007;27 Suppl 1:S101–24.CrossRefPubMed
38.
Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities. AJR Am J Roentgenol. 2013;200(2):329–36.CrossRefPubMed
39.
Espinosa LA, Daniel BL, Vidarsson L, Zakhour M, Ikeda DM, Herfkens RJ. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer. Radiology. 2005;237(2):429-36.CrossRefPubMed
40.
41.
Leide-Svegborn S, Ahlgren L, Johansson L, Mattsson S. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption. Eur J Nucl Med Mol Imaging. 2016;43(5):808–21.CrossRefPubMed
42.
Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Annex D. Recommendations on breast-feeding interruptions. Ann ICRP. 2015;44(2 Suppl):319–21.
43.
44.
Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? Cancer Treat Rev. 2013;39(3):207–11.CrossRefPubMed
45.
Griffin SJ, Milla M, Baker TE, Liu T, Wang H, Hale TW. Transfer of carboplatin and paclitaxel into breast milk. J Hum Lact. 2012;28(4):457–9.CrossRefPubMed
46.
Amato D, Niblett JS. Neutropenia from cyclophosphamide in breast milk. Med J Aust. 1977;1(11):383–4.PubMed
47.
Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc. 1979;71(2):165–6.PubMedPubMedCentral
48.
49.
50.
Urbaniak C, McMillan A, Angelini M, et al. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report. Microbiome. 2014;2:24.CrossRefPubMedPubMedCentral
51.
52.
Dominici LS, Kuerer HM, Babiera G, et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010;31(1):1–5.CrossRefPubMed
53.
Jindal S, Gao D, Bell P, et al. Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res. 2014;16(2):R31.CrossRefPubMedPubMedCentral
54.
Allegaert K, Miserez M, Lerut T, Naulaers G, Vanhole C, Devlieger H. Methemoglobinemia and hemolysis after enteral administration of methylene blue in a preterm infant: relevance for pediatric surgeons. J Pediatr Surg. 2004;39(1):E35–7.CrossRefPubMed
55.
Sills MR, Zinkham WH. Methylene blue-induced Heinz body hemolytic anemia. Arch Pediatr Adolesc Med. 1994;148(3):306–10.CrossRefPubMed
56.
Albert M, Lessin MS, Gilchrist BF. Methylene blue: dangerous dye for neonates. J Pediatr Surg. 2003;38(8):1244–5.CrossRefPubMed
57.
Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40(12):1932–47.CrossRefPubMed
58.
59.
Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev. 2018;4:CD002748.PubMed
60.
Eck DL, Perdikis G, Rawal B, Bagaria S, McLaughlin SA. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy. Ann Surg Oncol. 2014;21(10):3297–303.CrossRefPubMed
61.
Silva AK, Lapin B, Yao KA, Song DH, Sisco M. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol. 2015;22(11):3474–80.CrossRefPubMed
62.
Rieth EF, Barnett KM, Simon JA. Implementation and organization of a perioperative lactation program: a descriptive study. Breastfeed Med. 2018;13(2):97–105.CrossRefPubMedPubMedCentral
63.
Reece-Stremtan S, Campos M, Kokajko L, Medicine AoB. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, Revised 2017. Breastfeed Med. 2017;12(9):500–6.CrossRefPubMed
64.
65.
Murphy J, Sherman ME, Browne EP, et al. Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat. 2016;157(1):13–22.CrossRefPubMedPubMedCentral
Metadata
Title
Breastfeeding and Breast Cancer: Managing Lactation in Survivors and Women with a New Diagnosis
Authors
Helen M. Johnson, MD
Katrina B. Mitchell, MD
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07596-1

Other articles of this Issue 10/2019

Annals of Surgical Oncology 10/2019 Go to the issue

Breast Oncology

An Oncoplastic Surgery Primer: Common Indications, Techniques, and Complications in Level 1 and 2 Volume Displacement Oncoplastic Surgery

Breast Oncology

Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?

Breast Oncology

The 2018 Compensation Survey of the American Society of Breast Surgeons

Breast Oncology

Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing

Breast Oncology

A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction

Breast Oncology

DCIS with Microinvasion: Is It In Situ or Invasive Disease?